Altrafin AG’s Honeywell HON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-29,596
Closed -$6.5M 50
2025
Q2
$6.5M Sell
29,596
-4,912
-14% -$994K 2.19% 17
2025
Q1
$6.89M Buy
34,508
+414
+1% +$83.8K 2.68% 16
2024
Q4
$7.26M Sell
34,094
-753
-2% -$157K 2.52% 15
2024
Q3
$6.79M Sell
34,847
-8,064
-19% -$1.56M 2.45% 14
2024
Q2
$8.64M Buy
42,911
+1,988
+5% +$378K 3.19% 9
2024
Q1
$7.92M Hold
40,923
2.87% 11
2023
Q4
$8.09M Buy
40,923
+17,008
+71% +$3.07M 3.12% 7
2023
Q3
$4.16M Sell
23,915
-180
-0.7% -$32.9K 1.81% 22
2023
Q2
$4.71M Buy
24,095
+16
+0.1% +$2.97K 2.12% 16
2023
Q1
$4.34M Sell
24,079
-14,600
-38% -$2.75M 2.13% 21
2022
Q4
$7.81M Buy
38,679
+3,162
+9% +$604K 4.58% 4
2022
Q3
$5.59M Buy
35,517
+398
+1% +$69.3K 3.35% 6
2022
Q2
$5.75M Buy
35,119
+796
+2% +$143K 3.1% 5
2022
Q1
$6.29M Sell
34,323
-4,520
-12% -$836K 2.47% 9
2021
Q4
$7.63M Buy
+38,843
New +$7.84M 2.76% 8

Other funds holding HON

Altrafin AG's HON Position: Q3 2025 in Review

Altrafin AG sold out of Honeywell (HON) in Q3 2025, closing a stake of 29,596 shares — an estimated $6.5M sold.

Altrafin AG first reported a position in HON in Q4 2021 and held it in 15 quarters. The position peaked at $8.64M in Q2 2024. 2,649 funds tracked by Wall St. Rank hold HON as of Q3 2025.

  • Altrafin AG reported no remaining Honeywell position as of Q3 2025 after selling out during the quarter.
  • Altrafin AG sold 29,596 Honeywell shares in Q3 2025, an estimated $6.5M.
  • Altrafin AG first reported a position in Honeywell in Q4 2021 and held it in 15 quarters.
  • Altrafin AG's Honeywell position peaked at $8.64M in Q2 2024.
  • 2,649 funds tracked by Wall St. Rank held Honeywell as of Q3 2025.

Based on Altrafin AG's 13F filing for Q3 2025, filed 17 Feb 2026.